共 7 条
- [1] Shimizu K,et al.Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukine 2. Journal of Neurosurgery . 1987
- [2] Kalland T.et al.Analysis of the murine lymphokine-activityed killer(LAK)cell phenomenon:Dissection of effectors and progenitors into NK-and T-like cell. J Immunol . 1987
- [3] Merluzzi VJ,et al.Lysis of spontaneous murine breast tumors by human IL-2 stimulated syngenic T-lymphyocytes. Cancer Research . 1985
- [4] Donohue JH.et al.The systemic administration of purified interleukine 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngenic lymphoma. J Immunol . 1984
- [5] Grimm EA,et al.Lymphokine-activated killer cell phenomenon. The Journal of Experimental Medicine . 1982
- [6] Mahaley MS,et al.Experiences with antibody production from human glioma tissue. Progress in Experimental Tumor Research . 1972
- [7] Grimm EA.et al.Lymphokine-activated killer cell phenomenon Ⅲ,evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. The Journal of Experimental Medicine . 1983